Vascular Stent-EMEA Market Status and Trend Report 2013-2023
![](/report_cover/10724/vascular-stent-emea-market-status-n-trend-report-2013-2023_en.gif)
Report Summary
Vascular Stent-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Vascular Stent industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Vascular Stent 2013-2017, and development forecast 2018-2023
Main market players of Vascular Stent in EMEA, with company and product introduction, position in the Vascular Stent market
Market status and development trend of Vascular Stent by types and applications
Cost and profit status of Vascular Stent, and marketing status
Market growth drivers and challenges
The report segments the EMEA Vascular Stent market as:
EMEA Vascular Stent Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Vascular Stent Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
BMS
BVS
Drug Eluting
EMEA Vascular Stent Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Cardiology Center
ASC
EMEA Vascular Stent Market: Players Segment Analysis (Company and Product introduction, Vascular Stent Sales Volume, Revenue, Price and Gross Margin):
Medtronic
Abbott Laboratories
Boston Scientific Corporation
BIOTRONIK
B. Braun Melsungen
Terumo Corporation
STENTYS
MicroPort Scientific Corporation
Meril Life Sciences
Vascular Concepts
W. L. Gore and Associates
C. R. Bard
Endologix
Lombard Medical Technologies
Translumina
JOTEC
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Vascular Stent-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Vascular Stent industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Vascular Stent 2013-2017, and development forecast 2018-2023
Main market players of Vascular Stent in EMEA, with company and product introduction, position in the Vascular Stent market
Market status and development trend of Vascular Stent by types and applications
Cost and profit status of Vascular Stent, and marketing status
Market growth drivers and challenges
The report segments the EMEA Vascular Stent market as:
EMEA Vascular Stent Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Vascular Stent Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
BMS
BVS
Drug Eluting
EMEA Vascular Stent Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Cardiology Center
ASC
EMEA Vascular Stent Market: Players Segment Analysis (Company and Product introduction, Vascular Stent Sales Volume, Revenue, Price and Gross Margin):
Medtronic
Abbott Laboratories
Boston Scientific Corporation
BIOTRONIK
B. Braun Melsungen
Terumo Corporation
STENTYS
MicroPort Scientific Corporation
Meril Life Sciences
Vascular Concepts
W. L. Gore and Associates
C. R. Bard
Endologix
Lombard Medical Technologies
Translumina
JOTEC
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF VASCULAR STENT
1.1 Definition of Vascular Stent in This Report
1.2 Commercial Types of Vascular Stent
1.2.1 BMS
1.2.2 BVS
1.2.3 Drug Eluting
1.3 Downstream Application of Vascular Stent
1.3.1 Hospital
1.3.2 Cardiology Center
1.3.3 ASC
1.4 Development History of Vascular Stent
1.5 Market Status and Trend of Vascular Stent 2013-2023
1.5.1 EMEA Vascular Stent Market Status and Trend 2013-2023
1.5.2 Regional Vascular Stent Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Vascular Stent in EMEA 2013-2017
2.2 Consumption Market of Vascular Stent in EMEA by Regions
2.2.1 Consumption Volume of Vascular Stent in EMEA by Regions
2.2.2 Revenue of Vascular Stent in EMEA by Regions
2.3 Market Analysis of Vascular Stent in EMEA by Regions
2.3.1 Market Analysis of Vascular Stent in Europe 2013-2017
2.3.2 Market Analysis of Vascular Stent in Middle East 2013-2017
2.3.3 Market Analysis of Vascular Stent in Africa 2013-2017
2.4 Market Development Forecast of Vascular Stent in EMEA 2018-2023
2.4.1 Market Development Forecast of Vascular Stent in EMEA 2018-2023
2.4.2 Market Development Forecast of Vascular Stent by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Vascular Stent in EMEA by Types
3.1.2 Revenue of Vascular Stent in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Vascular Stent in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Vascular Stent in EMEA by Downstream Industry
4.2 Demand Volume of Vascular Stent by Downstream Industry in Major Countries
4.2.1 Demand Volume of Vascular Stent by Downstream Industry in Europe
4.2.2 Demand Volume of Vascular Stent by Downstream Industry in Middle East
4.2.3 Demand Volume of Vascular Stent by Downstream Industry in Africa
4.3 Market Forecast of Vascular Stent in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VASCULAR STENT
5.1 EMEA Economy Situation and Trend Overview
5.2 Vascular Stent Downstream Industry Situation and Trend Overview
CHAPTER 6 VASCULAR STENT MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Vascular Stent in EMEA by Major Players
6.2 Revenue of Vascular Stent in EMEA by Major Players
6.3 Basic Information of Vascular Stent by Major Players
6.3.1 Headquarters Location and Established Time of Vascular Stent Major Players
6.3.2 Employees and Revenue Level of Vascular Stent Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 VASCULAR STENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Medtronic
7.1.1 Company profile
7.1.2 Representative Vascular Stent Product
7.1.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Medtronic
7.2 Abbott Laboratories
7.2.1 Company profile
7.2.2 Representative Vascular Stent Product
7.2.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.3 Boston Scientific Corporation
7.3.1 Company profile
7.3.2 Representative Vascular Stent Product
7.3.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Boston Scientific Corporation
7.4 BIOTRONIK
7.4.1 Company profile
7.4.2 Representative Vascular Stent Product
7.4.3 Vascular Stent Sales, Revenue, Price and Gross Margin of BIOTRONIK
7.5 B. Braun Melsungen
7.5.1 Company profile
7.5.2 Representative Vascular Stent Product
7.5.3 Vascular Stent Sales, Revenue, Price and Gross Margin of B. Braun Melsungen
7.6 Terumo Corporation
7.6.1 Company profile
7.6.2 Representative Vascular Stent Product
7.6.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Terumo Corporation
7.7 STENTYS
7.7.1 Company profile
7.7.2 Representative Vascular Stent Product
7.7.3 Vascular Stent Sales, Revenue, Price and Gross Margin of STENTYS
7.8 MicroPort Scientific Corporation
7.8.1 Company profile
7.8.2 Representative Vascular Stent Product
7.8.3 Vascular Stent Sales, Revenue, Price and Gross Margin of MicroPort Scientific Corporation
7.9 Meril Life Sciences
7.9.1 Company profile
7.9.2 Representative Vascular Stent Product
7.9.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Meril Life Sciences
7.10 Vascular Concepts
7.10.1 Company profile
7.10.2 Representative Vascular Stent Product
7.10.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Vascular Concepts
7.11 W. L. Gore and Associates
7.11.1 Company profile
7.11.2 Representative Vascular Stent Product
7.11.3 Vascular Stent Sales, Revenue, Price and Gross Margin of W. L. Gore and Associates
7.12 C. R. Bard
7.12.1 Company profile
7.12.2 Representative Vascular Stent Product
7.12.3 Vascular Stent Sales, Revenue, Price and Gross Margin of C. R. Bard
7.13 Endologix
7.13.1 Company profile
7.13.2 Representative Vascular Stent Product
7.13.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Endologix
7.14 Lombard Medical Technologies
7.14.1 Company profile
7.14.2 Representative Vascular Stent Product
7.14.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Lombard Medical Technologies
7.15 Translumina
7.15.1 Company profile
7.15.2 Representative Vascular Stent Product
7.15.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Translumina
7.16 JOTEC
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VASCULAR STENT
8.1 Industry Chain of Vascular Stent
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VASCULAR STENT
9.1 Cost Structure Analysis of Vascular Stent
9.2 Raw Materials Cost Analysis of Vascular Stent
9.3 Labor Cost Analysis of Vascular Stent
9.4 Manufacturing Expenses Analysis of Vascular Stent
CHAPTER 10 MARKETING STATUS ANALYSIS OF VASCULAR STENT
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Vascular Stent in This Report
1.2 Commercial Types of Vascular Stent
1.2.1 BMS
1.2.2 BVS
1.2.3 Drug Eluting
1.3 Downstream Application of Vascular Stent
1.3.1 Hospital
1.3.2 Cardiology Center
1.3.3 ASC
1.4 Development History of Vascular Stent
1.5 Market Status and Trend of Vascular Stent 2013-2023
1.5.1 EMEA Vascular Stent Market Status and Trend 2013-2023
1.5.2 Regional Vascular Stent Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Vascular Stent in EMEA 2013-2017
2.2 Consumption Market of Vascular Stent in EMEA by Regions
2.2.1 Consumption Volume of Vascular Stent in EMEA by Regions
2.2.2 Revenue of Vascular Stent in EMEA by Regions
2.3 Market Analysis of Vascular Stent in EMEA by Regions
2.3.1 Market Analysis of Vascular Stent in Europe 2013-2017
2.3.2 Market Analysis of Vascular Stent in Middle East 2013-2017
2.3.3 Market Analysis of Vascular Stent in Africa 2013-2017
2.4 Market Development Forecast of Vascular Stent in EMEA 2018-2023
2.4.1 Market Development Forecast of Vascular Stent in EMEA 2018-2023
2.4.2 Market Development Forecast of Vascular Stent by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Vascular Stent in EMEA by Types
3.1.2 Revenue of Vascular Stent in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Vascular Stent in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Vascular Stent in EMEA by Downstream Industry
4.2 Demand Volume of Vascular Stent by Downstream Industry in Major Countries
4.2.1 Demand Volume of Vascular Stent by Downstream Industry in Europe
4.2.2 Demand Volume of Vascular Stent by Downstream Industry in Middle East
4.2.3 Demand Volume of Vascular Stent by Downstream Industry in Africa
4.3 Market Forecast of Vascular Stent in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VASCULAR STENT
5.1 EMEA Economy Situation and Trend Overview
5.2 Vascular Stent Downstream Industry Situation and Trend Overview
CHAPTER 6 VASCULAR STENT MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Vascular Stent in EMEA by Major Players
6.2 Revenue of Vascular Stent in EMEA by Major Players
6.3 Basic Information of Vascular Stent by Major Players
6.3.1 Headquarters Location and Established Time of Vascular Stent Major Players
6.3.2 Employees and Revenue Level of Vascular Stent Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 VASCULAR STENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Medtronic
7.1.1 Company profile
7.1.2 Representative Vascular Stent Product
7.1.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Medtronic
7.2 Abbott Laboratories
7.2.1 Company profile
7.2.2 Representative Vascular Stent Product
7.2.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.3 Boston Scientific Corporation
7.3.1 Company profile
7.3.2 Representative Vascular Stent Product
7.3.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Boston Scientific Corporation
7.4 BIOTRONIK
7.4.1 Company profile
7.4.2 Representative Vascular Stent Product
7.4.3 Vascular Stent Sales, Revenue, Price and Gross Margin of BIOTRONIK
7.5 B. Braun Melsungen
7.5.1 Company profile
7.5.2 Representative Vascular Stent Product
7.5.3 Vascular Stent Sales, Revenue, Price and Gross Margin of B. Braun Melsungen
7.6 Terumo Corporation
7.6.1 Company profile
7.6.2 Representative Vascular Stent Product
7.6.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Terumo Corporation
7.7 STENTYS
7.7.1 Company profile
7.7.2 Representative Vascular Stent Product
7.7.3 Vascular Stent Sales, Revenue, Price and Gross Margin of STENTYS
7.8 MicroPort Scientific Corporation
7.8.1 Company profile
7.8.2 Representative Vascular Stent Product
7.8.3 Vascular Stent Sales, Revenue, Price and Gross Margin of MicroPort Scientific Corporation
7.9 Meril Life Sciences
7.9.1 Company profile
7.9.2 Representative Vascular Stent Product
7.9.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Meril Life Sciences
7.10 Vascular Concepts
7.10.1 Company profile
7.10.2 Representative Vascular Stent Product
7.10.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Vascular Concepts
7.11 W. L. Gore and Associates
7.11.1 Company profile
7.11.2 Representative Vascular Stent Product
7.11.3 Vascular Stent Sales, Revenue, Price and Gross Margin of W. L. Gore and Associates
7.12 C. R. Bard
7.12.1 Company profile
7.12.2 Representative Vascular Stent Product
7.12.3 Vascular Stent Sales, Revenue, Price and Gross Margin of C. R. Bard
7.13 Endologix
7.13.1 Company profile
7.13.2 Representative Vascular Stent Product
7.13.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Endologix
7.14 Lombard Medical Technologies
7.14.1 Company profile
7.14.2 Representative Vascular Stent Product
7.14.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Lombard Medical Technologies
7.15 Translumina
7.15.1 Company profile
7.15.2 Representative Vascular Stent Product
7.15.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Translumina
7.16 JOTEC
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VASCULAR STENT
8.1 Industry Chain of Vascular Stent
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VASCULAR STENT
9.1 Cost Structure Analysis of Vascular Stent
9.2 Raw Materials Cost Analysis of Vascular Stent
9.3 Labor Cost Analysis of Vascular Stent
9.4 Manufacturing Expenses Analysis of Vascular Stent
CHAPTER 10 MARKETING STATUS ANALYSIS OF VASCULAR STENT
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference